Fuente: WIPO "tomato" The present disclosure is directed to compositions comprising fusion proteins of CD1d and anti-GD2 antibody that may be used as GD2-specific Bi-specific invariant natural killer T cell engagers (BiNTEs). Further provided herein are methods of using the fusion proteins or BiNTEs for the treatment of cancer.